Jiangsu Hengrui Pharmaceuticals (01276) had repurchased a total of 10.6944 million A shares as of the end of February.

Kangmei Pharmaceutical (01276) announced that as of February 28, 2026, the company's cumulative share repurchase program has repurchased a total of 10.6944 million shares through the Shanghai Stock Exchange trading system in a centralized competitive bidding manner. The repurchased shares account for 0.16% of the company's total share capital, with the highest purchase price at 70.00 RMB per share and the lowest at 56.10 RMB per share. The total amount paid is 697.7694 million RMB (excluding transaction costs).